Skip to content
Back to search

NCT06038227Recruiting

Lung cAncer Robotic Comparative Study

Summary

To compare outcomes of minimally invasive surgical techniques for the treatment of early-stage non-small cell lung cancer.

Inclusion criteria

• Patient diagnosed with clinical stage IA1-2 non-small cell lung cancer at time of procedure • Patient scheduled to undergo minimally invasive surgery for NSCLC with either da Vinci robotic assisted surgery or VATs • Aged ≥ 18 years • Must be willing and able to comply with study requirements • Must indicate their understanding of the study and willingness to participate by signing an appropriate informed consent form

Exclusion criteria

• Patients with clinical stage IA3, II, III, and IV lung cancer • Patient receiving a lobectomy/segmentectomy as an emergency procedure • Patients receiving a lobectomy/segmentectomy for metastatic cancer • Patients scheduled to receive a bilobectomy or sleeve-lobectomy • Mental incapacity to understand or consent to study procedures • Anticipated difficulty for patient to comply with protocol requirements • Unable to comply with the follow up schedule • Pregnant or are planning to become pregnant during the study • Life expectancy \< 12 months

Contacts

The trial team's contact details are shown on request.

See the official trial record
Status
Recruiting
Phase
—
Study type
Observational
Countries
Switzerland, France, Germany, Italy, Denmark, Norway, United Kingdom
Sponsor
Intuitive Surgical(Industry)
Protocol no.
1114332C
Conditions
Lung Cancer
Interventions
Procedure

Treatments studied

  • Robotic Assisted Thoracic Surgery
  • Video Assisted Thoracic Surgery

Locations · 13

  • Zurich, SwitzerlandUniversity Hospital ZurichRecruiting at this site
  • Marseille, FranceAP-HMRecruiting at this site
  • Rouen, FranceCHU de RouenRecruiting at this site
  • Toulouse, FranceCHU de ToulouseRecruiting at this site
  • Heidelberg, GermanyThoraxklinikRecruiting at this site
  • Regensburg, GermanyKrankenhaus Barmherzige BrüderRecruiting at this site
  • Pisa, ItalyAzienda Ospedaliero Universitaria PisanaRecruiting at this site
  • Copenhagen, DenmarkCopenhagen University Hospital RigshospitaletRecruiting at this site
  • Loerenskog, NorwayAkershus University HospitalRecruiting at this site
  • Bristol, United KingdomUniversity Hospitals Bristol and Weston NHS Foundation TrustRecruiting at this site
  • Coventry, United KingdomUniversity Hospitals Coventry and Warwickshire NHS TrustRecruiting at this site
  • London, United KingdomGuy's and St Thomas' NHS Foundation TrustRecruiting at this site
  • London, United KingdomSt Bartholomew HospitalRecruiting at this site

In total, worldwide, all 13 sites listed in the registry are recruiting.

Site status per the ClinicalTrials.gov registry (last update posted: September 14, 2026).

This status may have changed and says nothing about your eligibility: before taking any step, check with your oncologist or the site.

See also

Other versions

These results are indicative and do not replace medical advice — discuss them with your doctor.